Myocardial PD-L1 Expression in Patients With Ischemic and Non-ischemic Heart Failure
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2021.759972
Abstract: Objective: Immune checkpoints inhibitors are promising and wide-spread agents in anti-cancer therapy. However, despite their efficacy, these agents could cause cardiotoxicity, a rare but life-threatening event. In addition, there are still no well-described predictive factors… read more here.
Keywords: ischemic heart; cardiovascular diseases; expression patients; expression ... See more keywords